SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?


To: Robert K. who wrote (9671)4/17/1999 9:36:00 AM
From: BostonView  Respond to of 17367
 
XOMA's already enough of a conundrum without asking Riddler-like questions. Do YOU believe???

I'm buying more under $3. It's taking me from "funny money" into real dollars. The stakes are going up and the time is drawing near. Either way, I'm prepared for tears (rejoice or anguish).

The volume and price action has been curious the last week or so. It's either an evenly matched battle between the bulls and bears, or our friendly MM's are "managing" the price to someone's advantage.

Back to lurking,

BV



To: Robert K. who wrote (9671)4/17/1999 11:08:00 AM
From: aknahow  Read Replies (2) | Respond to of 17367
 
XOMA, Jack Castello, HELLO! It is not enough to tell shareholders about your meetings. Some crumbs of information are desirable. XOMA has said nothing about any of these events.

March '99

International Symposium on Intensive Care and Emergency Medicine
14-19, Brussels, Belgium

Pat Scannon, MD, PhD, rBPI-21 Clinical Update

Bio Partnering Asia
8-9, Tokyo, Japan

Jack Castello, CEO, Partnering Presentation

American Chemical Society
21-25, Anaheim, CA

Marc Better, PhD, Session Chair: Recent Developments in Expression Systems

Pat Gavit, XOMA Scientist, "Isolation of Anti-fungal Peptides from Escherichia
coli after Simultaneous in situ Lysis and Peptide Cleavage"

April '99

Sutro & Co. Second Annual Healthcare Conference
7-9, San Diego, California

Jack Castello, CEO, Corporate Presentation

Super Bugs and Super Drugs
13-14, London, England

Pat Scannon, MD, PhD, rBPI-21 Clinical Update

BioCentury Conference, Carson Group
15, New York

Jack Castello, CEO, Corporate Presentation

XXXXXXXXXXXXXXXX

We found a link to the presentation in Japan site and something it would have been nice if XOMA had provided at least this type of information.



To: Robert K. who wrote (9671)4/20/1999 6:57:00 PM
From: aknahow  Read Replies (1) | Respond to of 17367
 
Bob, CETP.

Message 9033527

Bob, BTW please don't dismiss voting no. It will not hurt XOMA and could help all shareholders.